Tetracycline's Synthesis of Amino-N-(Lysinomethyl)-Tetracycline as a new Antibiotic

  • Himmat M. A. Fadul
Keywords: Tetracycline's, antibacterial, lysinomethyl

Abstract

Tetracycline's, (TCs) are well-known as antibiotics and their antibacterial action is recognized as very dynamic molecules. Emerging new technological advances in research have led to the search for the synthesis of further derivatives of tetracyclines that endow new characteristics and properties that fortify their therapeutic actions. A large number of alkyl derivatives have been synthesized in order to correlate their structure and reactivity with their pharmacological potential. One of the targets of this study is to attempt a chemical synthesis to produce two such derivatives. The second aim of this work is to introduce a new framework for the classification of old and new generations of TCs, using a medicinal chemistry approach to the structure of those drugs The Mannich base reaction was adopted for the synthesis of two tautomeric forms of amino-N-(lysinomethyl)-tetracycline. The reaction included a three-component-single-pot reaction in which a secondary amine reacts with an aldehyde, tetrahydrofuran and an active hydrogen compound. The attempt was successfully carried out and yielded the two isomers. The confirmatory tests were carried out employing the NMR Spectroscopy detection technique. The main aim of this study is to prepare two isomers of amino-N-(lysinomethyl)-tetracycline as a new antibiotic. The study also makes attempts for a drug discovery.

References

1. Agnihotri R, Gaur S. Chemically modified tetracyclines:Novel Therapeutic agents in the management of Chronic Periodontitis. Indial J Pharmacol 2012;44:161.
2. SapadinAN, FleischmajerR. Tetracyclines:Non-Antibiotic Properties and their clinical implications. JAmAcadDermatol 2006;54:258-65.
3. .Patel RN, Attur MG, Dave MN, Patel IV, StuchinSA,AbramsonSB,Amin AR. A Novel Mechanism of Action ofChemically Modified Tetracyclines: Inhibition of Cox-2-Mediated Prostaglandin E2 production. J Immunol1999;163:3459.
4. Weinberg MA, Bral M. Tetracycline and Its Analogues: a Therapeutic Paradigm in Periodontal Diseases. CritRevOral Bio Med 1998;9(3):322.
5. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J,Sorsa T. Tetracylines inhibit connective tissuebreakdown by multiple non-antibacterial mechanisms.Adv Dent Res 1998;12:12.Tetracyclines. Microbial Ecology in Health and Disease2004;16:1.
6. Roy SK,Kendrick D, Sadowitz BD, Gatto L, SynderK,Satalin JM et al. Jack Of All Trades: Pleiotropy And TheApplication Of Chemically M T-3 In Sepsis And Ards.Pharmacol Res 2011;64:580.
7. Ramamurthy NS, Rifkin BR, Greenwald RA, Xu J, Liu Y,Turner G, Golub LM, Vernillo AT. Inhibition of MatrixMetalloproteinase- Mediated Periodontal bone loss inrats: A Comparison of 6 Chemically ModifiedTetracyclines. J Periodontol 2002;73:726.
Published
2016-10-01